From the Guidelines
For asthma with laryngitis and cough, inhaled corticosteroids (ICS) are the best therapeutic option, as they have been shown to be effective in reducing symptoms. According to the Chest guideline and expert panel report 1, the evidence supports the use of ICS as the primary treatment for chronic cough due to asthma. The report states that the best therapeutic option for cough in asthma is inhaled corticosteroids, followed by leukotriene receptor antagonism.
Some examples of ICS that can be used for asthma with laryngitis and cough include:
- Fluticasone (Flovent)
- Budesonide (Pulmicort) These medications are available in various strengths and can be adjusted based on symptom control.
It's also important to note that proper inhaler technique is crucial to ensure the medication is delivered effectively to the lungs. This includes:
- Inhaling slowly and deeply
- Holding breath for 10 seconds
- Rinsing the mouth afterward to prevent thrush A healthcare provider should determine the specific medication and dosage based on the individual's symptom severity, medical history, and response to treatment.
From the FDA Drug Label
The subjective impact of asthma on subjects’ perception of health was evaluated through use of an instrument called the Asthma Quality of Life Questionnaire (AQLQ) Efficacy results in this trial were similar to those observed in Trial 1. Subjects receiving fluticasone propionate and salmeterol inhalation powder 250 mcg/50 mcg had significantly greater improvements in FEV1 (0.48 L, 23%) Statistically significantly fewer subjects receiving fluticasone propionate and salmeterol inhalation powder 250 mcg/50 mcg were withdrawn from this trial for worsening asthma (4%)
The best steroid inhaler for asthma, laryngitis, and cough is fluticasone propionate and salmeterol inhalation powder.
- Key benefits of this inhaler include:
- Improved FEV1 (forced expiratory volume in 1 second)
- Reduced asthma symptoms
- Improved quality of life as measured by the Asthma Quality of Life Questionnaire (AQLQ)
- Fewer withdrawals due to worsening asthma 2
From the Research
Treatment Options for Asthma
- Inhaled corticosteroids (ICS) are a common treatment for asthma, with options including fluticasone propionate and budesonide 3, 4, 5.
- Long-acting beta-agonists (LABAs) such as salmeterol and formoterol can be used in combination with ICS for improved symptom control 4, 6, 5.
- Combination therapies, such as budesonide/formoterol and fluticasone/salmeterol, have been shown to be effective in improving lung function and symptom control 4, 6, 5.
Specific Steroid Inhalers for Asthma, Laryngitis, and Cough
- Fluticasone propionate is a commonly used ICS, with a standard daily dose of 200-250 μg 3.
- Budesonide/formoterol is a combination therapy that has been shown to be effective in treating persistent asthma 4.
- Salmeterol/fluticasone propionate is another combination therapy that has been shown to be effective in improving lung function and symptom control 6, 5.
Comparison of Treatment Options
- Studies have compared the effectiveness of different ICS and LABA combinations, with fluticasone and formoterol appearing to provide improved therapeutic benefits compared to budesonide and salmeterol 5.
- Pharmacoeconomic analyses have shown that salmeterol/fluticasone propionate is a cost-effective treatment option for patients with asthma not controlled with inhaled corticosteroid therapy 7.